Principal Financial Group Inc. boosted its stake in Cantel Medical Corp. (NYSE:CMN) by 2.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 259,647 shares of the company’s stock after buying an additional 6,971 shares during the period. Principal Financial Group Inc. owned about 0.63% of Cantel Medical Corp. worth $17,844,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in the company. Henderson Group PLC increased its position in Cantel Medical Corp. by 51.1% in the second quarter. Henderson Group PLC now owns 680,016 shares of the company’s stock worth $46,737,000 after buying an additional 230,084 shares in the last quarter. Neuberger Berman Group LLC increased its position in Cantel Medical Corp. by 23.1% in the second quarter. Neuberger Berman Group LLC now owns 952,754 shares of the company’s stock worth $65,483,000 after buying an additional 179,096 shares in the last quarter. Kalmar Investments Inc. DE increased its position in Cantel Medical Corp. by 68.4% in the second quarter. Kalmar Investments Inc. DE now owns 285,232 shares of the company’s stock worth $19,604,000 after buying an additional 115,832 shares in the last quarter. Advisors Asset Management Inc. acquired a new position in Cantel Medical Corp. during the second quarter worth about $6,672,000. Finally, Congress Asset Management Co. MA acquired a new position in Cantel Medical Corp. during the second quarter worth about $4,608,000. 81.61% of the stock is currently owned by institutional investors and hedge funds.
Shares of Cantel Medical Corp. (NYSE:CMN) traded up 0.47% on Tuesday, hitting $79.00. 7,816 shares of the company’s stock were exchanged. Cantel Medical Corp. has a 12-month low of $52.23 and a 12-month high of $81.63. The stock has a market cap of $3.27 billion, a price-to-earnings ratio of 54.94 and a beta of 1.59. The company’s 50-day moving average price is $76.46 and its 200 day moving average price is $70.77.
Cantel Medical Corp. (NYSE:CMN) last announced its quarterly earnings data on Thursday, September 29th. The company reported $0.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.11. Cantel Medical Corp. had a net margin of 9.02% and a return on equity of 16.70%. The business had revenue of $179 million for the quarter. During the same quarter in the previous year, the business posted $0.39 earnings per share. Cantel Medical Corp.’s revenue for the quarter was up 18.3% compared to the same quarter last year. On average, equities analysts predict that Cantel Medical Corp. will post $1.98 earnings per share for the current fiscal year.
A number of research analysts recently issued reports on CMN shares. Needham & Company LLC started coverage on shares of Cantel Medical Corp. in a research report on Wednesday, August 24th. They set a “hold” rating for the company. Benchmark Co. started coverage on shares of Cantel Medical Corp. in a research report on Monday, August 29th. They set a “buy” rating and a $83.00 target price for the company.
Cantel Medical Corp. Company Profile
Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.